[Coronary angioplasty in women].
The cardiovascular risk is the main cause of mortality and is increasing with age in women. In old women, this risk is similar to men. Many cardiovascular treatments are used in women without a clear demonstration of their efficiency in this population. It is only extrapolations of studies enrolling a large majority of males (more than 85%). It is very important to improve our therapeutic strategies in women, for all clinical presentations (stable angina or acute coronary syndromes), to perform dedicated studies. In fact, the rate of success of coronary angioplasty in women is similar to men but the prognosis is worse. This is partly explained by a waiting-game in the strategy and some anatomic differences such as smaller vessels diameters and also a high rate of vascular complications. To decrease this risk of vascular complications, the use of transradial seems to be a good solution. In another hand, in women, the use of drug eluting stent (DES) gives good results comparable to men. But no study has been dedicated to this group of patients.